Atıf İçin Kopyala
Papatheodoridis G., Dalekos G., Sypsa V., Yurdaydin C., Buti M., Goulis J., ...Daha Fazla
JOURNAL OF HEPATOLOGY, cilt.64, sa.4, ss.800-806, 2016 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
64
Sayı:
4
-
Basım Tarihi:
2016
-
Doi Numarası:
10.1016/j.jhep.2015.11.035
-
Dergi Adı:
JOURNAL OF HEPATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.800-806
-
Anahtar Kelimeler:
Hepatocellular carcinoma, Hepatitis B, Entecavir, Tenofovir, RECEIVING ENTECAVIR, CIRRHOSIS, SCORES, VALIDATION, LAMIVUDINE
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background & Aims: Risk scores for hepatocellular carcinoma (HCC) developed in Asians offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This nine center cohort study aimed to develop and validate an accurate HCC risk score in Caucasian CHB patients treated with the current oral antivirals, entecavir/tenofovir.